1-8 of 8
Natalia Lazorko
Close
Sort by
Journal Articles

The Updated Results of Asciminib Managed-Access Program (MAP) in Patients with Chronic Myeloid Leukemia in Russia

Elena Kuzmina, Ekaterina Chelysheva, Elza Lomaia, Elena V Morozova, Oleg Shukhov, Anna Petrova, Tamara Chitanava, Julia Vlasova, Evgenia Sbitiakova, Natalia Lazorko, Irina Nemchenko, Anastasiya Vitalievna Bykova, Margarita Gurianova, Alina Kokhno, Anna Turkina
Journal: Blood
Blood (2023) 142 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2023-181789
Published: 2023
Journal Articles

Comparative Characteristics of the Effectiveness of Tyrosine Kinase Inhibitors Vs Allogeneic Hematopoietic Stem Cell Transplantation in the Chronic Phase of Chronic Myeloid Leukemia

Elza Lomaia, Tamara Chitanava, Yulia Vlasova, Dmitry Motorin, Sergey Voloshin, Darina Zammoeva, Renat Badaev, Yulia Matvienko, Elizaveta Efremova, Ekaterina Mileeva, Nadia Siordia, Olga Kulemina, Eugenia Sbityakova, Natalia Lazorko, Julia Alexeeva, Irina Martynkevich, Elena Karyagina, Natalia Ilyina, Nadezhda Medvedeva, Natalia Dorofeeva, Tatiana Shneider, Svetlana Stepanova, Vasily Shuvaev, Elena Morozova
Journal: Blood
Blood (2022) 140 (Supplement 1): 12192–12193.
https://doi.org/10.1182/blood-2022-163506
Published: 2022
Journal Articles

Baseline Cytogenetic Response Is a Predictor of Outcome of Third Line 2 nd Generation TKI Treatment in Chronic Phase Chronic Myeloid Leukemia Patients

Natalia Lazorko, MD, Elza Lomaia, MD, Vasily Shuvaev, MD PhD, Irina Martynkevich, Mikhail Fominykh, MD, Anna Silyutina, MD, Katerina Ovsiannikova, Nadia Siordia, MD, Andrey Zaritskey, Elena Machulaytene, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5255.
https://doi.org/10.1182/blood.V130.Suppl_1.5255.5255
Published: 2017
Journal Articles

Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia

Elza Lomaia, MD PhD, Andrey Zaritskey, MD, Vasily Shuvaev, MD, Irina Martynkevich, MD PhD, Mikhail Fominykh, MD, Ekaterina Ovsyannikova, MD, Natalia Lazorko, MD, Natalia Matyuhina, MS, Pavel Butylin, PhD, Elena Machyulaitene, MD, Evgenia Salamatova, MD, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4051.
https://doi.org/10.1182/blood.V126.23.4051.4051
Published: 2015
Journal Articles

Efficacy Of Different Therapeutic Approaches In Blastic Phase Of Chronic Myeloid Leukemia: Single Centre Experience

Elza Lomaia, MD, PhD, Ekaterina Romanova, MD, Larisa Girshova, MD, Yulia Alexeeva, MD, PhD, Eugenia Sbityakova, MD, Elena Goriunova, MD, Vladimir Strugov, MD, Natalia Lazorko, MD, Nadia Siordia, MD, Diana Mescheryakova, MD, Tatiana Silina, MD, Dmitry Motorin, MD, PhD, Andrey Zaritskey, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5173.
https://doi.org/10.1182/blood.V122.21.5173.5173
Published: 2013
Journal Articles

Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011

Kudrat Abdulkadyrov, Elza Lomaia, Natalia Lazorko, Vasiliy Shuvaev, Alla Abdulkadyrova, Irina Martinkevich, Elena Usacheva, Vera Udalieva, Irina Zotova, Elena Machulaitene, Natalia Ilina, Elena Karyagina, Irina Kholopova, Ekaterina Romanova, Eugenia Sbityakova, Tatiana Shneider, Andrey Zaritskey
Journal: Blood
Blood (2012) 120 (21): 4432.
https://doi.org/10.1182/blood.V120.21.4432.4432
Published: 2012
Journal Articles

Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment

Irina Dyagil, Elza Lomaia, Kudrat Abdulkadirov, Elena Goryunova, Natalia Lazorko, Ekaterina Romanova, Eugenia Sbityakova, Alla Abdulkadirova, Irina Martinkevich, Vera Udalieva, Elena Usacheva, Irina Zotova, Vasiliy Shuvaev, Elena Machulaitene, Ekaterina Poznyak, Maria Ivanova, Natalia Ilina, Elena Koryagina, Tatiana Shneider, Svetlana Stepanova, Irina Dmitrenko, Natalia Babkina, Tatiana Perekhrestenko, Zvenyslava Masliak, Andrey Zaritskey
Journal: Blood
Blood (2011) 118 (21): 4452.
https://doi.org/10.1182/blood.V118.21.4452.4452
Published: 2011
Journal Articles

Only Time Before the Beginning of Treatment and Time to Achieve CCyR Influence the Stability of CCyR In CML-CP Patients On Imatinib Therapy.

Kudrat Abdulkadyrov, Elza Lomaia, Alla Abdulkadyrova, Vera Udalieva, Dgariyat Shikhbabaeva, Elena Usacheva, Irina Zotova, Elena Machulaitene, Maria Ivanova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Evgenia Salamatova, Natalia Lazorko, Irina Martynkevich, Vasiliy Shuvaev, Andrey Zaritskey
Journal: Blood
Blood (2010) 116 (21): 4476.
https://doi.org/10.1182/blood.V116.21.4476.4476
Published: 2010